date,title,source
Oct-24-18,"What is Next for Histogenics, Pending FDA Meeting and Analysts Target Price",ACCESSWIRE
Oct-25-18,"Histogenics Corporation to Report Third Quarter 2018 Financial Results on November 8, 2018",GlobeNewswire
Nov-01-18,Histogenics and FDA to Continue Discussions on NeoCart Phase 3 Clinical Trial Data and Potential Regulatory Pathway,GlobeNewswire
